Asie · Presse financière · The Economic Times

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

Publié par The Economic Times · Inde il y a 4 h

Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong…

Lire l'article complet sur The Economic Times Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (economictimes.indiatimes.com)

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

À lire aussi

China’s Communist Party Fills 10 Central Committee Vacancies

Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Uniqlo shakes up China strategy with focus on store profitability

Sun Pharma Q2 profit falls 36% as litigation costs hit earnings

Partager

À lire aussi

China’s Communist Party Fills 10 Central Committee Vacancies

Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Uniqlo shakes up China strategy with focus on store profitability